Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jolaine M. Hines"'
Autor:
Kittrawee Kritmetapak, Louis Losbanos, Taylor E. Berent, Susan L. Ashrafzadeh-Kian, Alicia Algeciras-Schimnich, Jolaine M. Hines, Ravinder J. Singh, Rajiv Kumar
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-8 (2021)
Abstract Background Hyperphosphatemia confers adverse cardiovascular outcomes, and commonly occurs in late-stage CKD. Fibroblast growth factor 7 (FGF7) is a phosphaturic peptide which decreases renal phosphate transport in vitro and in vivo. Serum FG
Externí odkaz:
https://doaj.org/article/442359481de8413eb53bf77f668481be
Autor:
Richard T. Waldron, Elaina K. Jones, Vincent I. Anani, Jolaine M. Hines, Jing Zhao, Aurelia Lugea, Marcio A. Diniz, Sungjin Kim, Aida Habtezion, Kristi L. Hoffman, Joseph F. Petrosino, William E. Fisher, Liang Li, Ryan J. Lennon, Ravinder Jit Singh, Santhi Swaroop Vege, Stephen J. Pandol, Mark D. Topazian
Publikováno v:
Pancreas. 51(7)
Chronic pancreatitis (CP) is a chronic fibroinflammatory condition of the pancreas difficult to diagnose in early stages. Novel biomarkers useful to facilitate early diagnosis or treatment responses may be found in biofluids. Although saliva can be e
Autor:
Matthew T. Drake, Jolaine M. Hines, Joshua N. Farr, Ravinder J. Singh, Katherine L O'Grady, Amanda J Tweed, Olga P. Bondar, Brittany A. Eckhardt, Brianne S Thicke, Sara J. Achenbach, Tammie L Volkman, Sundeep Khosla, Elizabeth J. Atkinson
Publikováno v:
J Appl Lab Med
BackgroundAdvanced glycation end products (AGEs) are formed via the nonenzymatic glycation of sugars with amino acids. Two AGEs, Nε-(1-carboxymethyl)-L-Lysine (CML) and pentosidine, have been observed to be elevated in subjects suffering from a mult
Publikováno v:
Clin Chem
Publikováno v:
Biochem Biophys Res Commun
Background Novel human parathyroid hormone (hPTH) peptides of unknown biological activity have recently been identified in the serum of subjects with normal renal function, chronic renal failure, and end-stage renal disease through the application of
Autor:
Irina Bancos, Pavel N. Pichurin, Ravinder J. Singh, Ravinder Kaur, Stefan K.G. Grebe, Jolaine M. Hines
Publikováno v:
Journal of the Endocrine Society
Objective Adrenocortical carcinoma (ACC) is a rare malignancy with poor prognosis. ACC was reported in 3.2% patients with Lynch syndrome (LS), however no particular case-detection strategies have been recommended. Participants We report a case of a 6
Autor:
Rajiv Kumar, Susan Ashrafzadeh-Kian, Alicia Algeciras-Schimnich, Jolaine M. Hines, Ravinder J. Singh, Taylor E. Berent, Kittrawee Kritmetapak, Louis L. Losbanos
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-8 (2021)
Background Hyperphosphatemia confers adverse cardiovascular outcomes, and commonly occurs in late-stage CKD. Fibroblast growth factor 7 (FGF7) is a phosphaturic peptide which decreases renal phosphate transport in vitro and in vivo. Serum FGF7 concen
Autor:
Kittrawee, Kritmetapak, Louis, Losbanos, Taylor E, Berent, Susan L, Ashrafzadeh-Kian, Alicia, Algeciras-Schimnich, Jolaine M, Hines, Ravinder J, Singh, Rajiv, Kumar
Publikováno v:
BMC Nephrology
Background Hyperphosphatemia confers adverse cardiovascular outcomes, and commonly occurs in late-stage CKD. Fibroblast growth factor 7 (FGF7) is a phosphaturic peptide which decreases renal phosphate transport in vitro and in vivo. Serum FGF7 concen
Autor:
Katherine L O'Grady, Kittrawee Kritmetapak, Jolaine M. Hines, Hubert W. Vesper, Ravinder J. Singh, Rajiv Kumar, Louis A Losbanos, Candice Z. Ulmer, Felicity Enders
Publikováno v:
Clinical Chemistry
Background The precise concentrations of full-length parathyroid hormone (PTH1-84) and the identity and concentrations of PTH fragments in patients with various stages of chronic renal failure are unknown. Methods We developed a liquid chromatography
Autor:
Katherine L O'Grady, Brianne S Thicke, João F. Passos, Jennifer L. Rowsey, Olga P. Bondar, Aleksey V. Matveyenko, Brittany A. Eckhardt, David G. Monroe, Anthony B. Lagnado, Ravinder J. Singh, Sundeep Khosla, Daniel G. Fraser, Adrian Vella, Jolaine M. Hines, Joshua N. Farr, Andrew R. Thoreson, Kuntol Rakshit
Publikováno v:
JCI Insight
The worldwide prevalence of type 2 diabetes (T2D) is increasing. Despite normal to higher bone density, patients with T2D paradoxically have elevated fracture risk resulting, in part, from poor bone quality. Advanced glycation endproducts (AGEs) and